|
Volumn 17, Issue 2, 2002, Pages 130-139
|
Immune reconstitution after hematopoietic stem-cell transplantation and its influence on respiratory infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
CASPOFUNGIN;
COTRIMOXAZOLE;
FOSCARNET;
GANCICLOVIR;
IMMUNOGLOBULIN;
ITRACONAZOLE;
POSACONAZOLE;
RAVUCONAZOLE;
VORICONAZOLE;
ANTIBODY PRODUCTION;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE;
CLINICAL TRIAL;
DRUG CHOICE;
DRUG INDICATION;
GRAFT VERSUS HOST REACTION;
HEMATOLOGIC DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNE SYSTEM;
INFECTION RISK;
INFECTION SENSITIVITY;
NEUTROPENIA;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESPIRATORY TRACT INFECTION;
REVIEW;
RISK ASSESSMENT;
SURVIVAL RATE;
T LYMPHOCYTE;
VIRUS PATHOGENESIS;
B-LYMPHOCYTES;
DIAGNOSIS, DIFFERENTIAL;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
RESPIRATORY TRACT INFECTIONS;
TRANSPLANTATION CONDITIONING;
|
EID: 0036089350
PISSN: 08820546
EISSN: None
Source Type: Journal
DOI: 10.1053/srin.2002.33441 Document Type: Review |
Times cited : (18)
|
References (38)
|